{"mainPropery":{"diseaseId":10958,"diseaseName":"Oculocutaneous albinism","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10958/oculocutaneous-albinism","synonyms":["OCA","Albinism, Oculocutaneous"],"synonyms-with-source":[{"name":"OCA"},{"name":"Albinism, Oculocutaneous"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"55"}]},"diseaseCategories":[],"organizations":[{"resourceID":110,"resourceName":"National Alliance for Eye and Vision Research ","abbreviation":"NAEVR","address1":"1801 Rockville Pike, Suite 400","address2":"","address3":"","address4":"","address5":"","city":"Rockville","state":"MD","zip":"20852","country":"United States","phone":"+1-240-221-2905","tty":"","tollFree":"","fax":"","email":"jamesj@eyeresearch.org","url":"https://www.eyeresearch.org/","freeText":""},{"resourceID":289,"resourceName":"The National Organization of Albinism and Hypopigmentation (NOAH)","address1":"PO Box 959","address2":"","address3":"","address4":"","address5":"","city":"East Hampstead","state":"NH","zip":"03826-0959 ","country":"United States","phone":"603-887-2310 ","tty":"","tollFree":"800-473-2310; ","fax":"","email":"noah@albinism.org","url":"http://www.albinism.org"},{"resourceID":478,"resourceName":"Vision of Children Foundation ","abbreviation":"VOC","address1":"12555 High Bluff Drive, Suite 330","address2":"","address3":"","address4":"","address5":"","city":"San Diego","state":"CA","zip":"92130 ","country":"United States","phone":"+1-858-314-7916","tty":"","tollFree":"","fax":"","email":"info@visionofchildren.org","url":"https://www.visionofchildren.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=oculocutaneous%20albinism' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Oculocutaneous albinism. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?term=oculocutaneous+albinism' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Oculocutaneous albinism. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/oculocutaneous-albinism' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Oculocutaneous albinism. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001479.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=55' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0050632' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2340,"resourceId":3583,"resourceName":"Job Accommodation Network","descriptionText":"The <a href='https://askjan.org/disabilities/Albinism.cfm' target='_blank'>Job Accommodation Network</a> (JAN) has information on workplace accommodations and disability employment issues related to this condition. JAN is a service of the Office of Disability Employment Policy in the U.S. Department of Labor.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Community Resources"}],"overviewQuestion":{"questionId":6490,"questionText":"What is oculocutaneous albinism?","answerText":"<strong>Oculocutaneous albinism</strong> is a group of conditions that affect the coloring of the hair and eyes.&nbsp; Individuals affected by oculocutaneous albinism have very light skin and light-colored <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002386.htm\" target=_blank>irises</a>; they may also have vision problems such as decreased sharpness of vision, rapid eye movements (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003037.htm\" target=_blank>nystagmus</a>), crossed eyes (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001004.htm\" target=_blank>strabismus</a>), or increased sensitivity to light (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003041.htm\" target=_blank>photophobia</a>).&nbsp; All types of oculocutaneous albinism are caused by <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=_blank>gene</a> <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=_blank>mutations</a> that are <a href=\"http://ghr.nlm.nih.gov/glossary=geneticinheritance\" target=_blank>inherited</a> in an <a href=\"http://ghr.nlm.nih.gov/handbook/illustrations/autorecessive\" target=_blank>autosomal recessive</a> manner.&nbsp; Treatment includes covering the skin from sun exposure by using sunscreen and protective clothing and attending to vision problems by wearing glasses.[4372]","dateModified":"2012-10-17T12:38:00"},"basicQuestions":[{"questionId":6489,"questionText":"What treatments are available for oculocutaneous albinism?","answerText":"Individuals with oculocutaneous albinism should have annual skin examinations to check for skin damage or skin cancer and annual eye examination to check vision.&nbsp; Affected individuals should cover their skin from sun exposure by using sunscreen and wearing protective clothing such as long-sleeve shirts, long pants,&nbsp;and hats with wide brims.&nbsp; Glasses may be worn to reduce sensitivity to bright light or to improve vision.&nbsp;&nbsp;Additional therapies or surgery&nbsp;may be used to&nbsp;treat crossed eyes (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001004.htm\" target=_blank>strabismus</a>) or rapid eye movements (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003037.htm\" target=_blank>nystagmus</a>).[5562][5563][5564]","dateModified":"2012-10-15T07:52:00","resourceClassificationName":"Treatment","references":[{"referenceId":5562,"authors":"","articleTitle":"Albinism","bookWebsiteJournalTitle":"MedlinePlus","date":"November 2011","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001479.htm","dateAccessed":"2012-10-15T00:00:00"},{"referenceId":5563,"authors":"Lewis RA","articleTitle":"Oculocutaneous Albinism Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"August 2012","url":"http://www.ncbi.nlm.nih.gov/books/NBK1232/","dateAccessed":"2012-10-15T00:00:00"},{"referenceId":5564,"authors":"King RA","articleTitle":"Oculocutaneous Albinism Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"October 2004","url":"http://www.ncbi.nlm.nih.gov/books/NBK1166/","dateAccessed":"2012-10-15T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":36880,"abbreviatedInquiry":"My child has vision issues and a skin condition, which has been diagnosed as oculocutaneous albinism.&nbsp; Are there things&nbsp;I need to know about this condition other than keeping my daughter's skin covered?","caseQuestions":[{"questionId":6489,"questionText":"What treatments are available for oculocutaneous albinism?","answerText":"Individuals with oculocutaneous albinism should have annual skin examinations to check for skin damage or skin cancer and annual eye examination to check vision.&nbsp; Affected individuals should cover their skin from sun exposure by using sunscreen and wearing protective clothing such as long-sleeve shirts, long pants,&nbsp;and hats with wide brims.&nbsp; Glasses may be worn to reduce sensitivity to bright light or to improve vision.&nbsp;&nbsp;Additional therapies or surgery&nbsp;may be used to&nbsp;treat crossed eyes (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001004.htm\" target=_blank>strabismus</a>) or rapid eye movements (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003037.htm\" target=_blank>nystagmus</a>).[5562][5563][5564]","dateModified":"2012-10-15T07:52:00","resourceClassificationName":"Treatment","references":[{"referenceId":5562,"authors":"","articleTitle":"Albinism","bookWebsiteJournalTitle":"MedlinePlus","date":"November 2011","url":"http://www.nlm.nih.gov/medlineplus/ency/article/001479.htm","dateAccessed":"2012-10-15T00:00:00"},{"referenceId":5563,"authors":"Lewis RA","articleTitle":"Oculocutaneous Albinism Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"August 2012","url":"http://www.ncbi.nlm.nih.gov/books/NBK1232/","dateAccessed":"2012-10-15T00:00:00"},{"referenceId":5564,"authors":"King RA","articleTitle":"Oculocutaneous Albinism Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"October 2004","url":"http://www.ncbi.nlm.nih.gov/books/NBK1166/","dateAccessed":"2012-10-15T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8275,"phenoTypeName":"Cutaneous photosensitivity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":896,"phenoTypeName":"Generalized hypopigmentation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10579,"phenoTypeName":"Iris hypopigmentation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4206,"phenoTypeName":"White hair","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10489,"phenoTypeName":"Astigmatism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14892,"phenoTypeName":"High hypermetropia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10583,"phenoTypeName":"Hypoplasia of the fovea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5650,"phenoTypeName":"Myopia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9198,"phenoTypeName":"Photophobia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5614,"phenoTypeName":"Visual impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8102,"phenoTypeName":"White eyelashes","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13296,"phenoTypeName":"Basal cell carcinoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7951,"phenoTypeName":"Melanoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":99,"phenoTypeName":"Squamous cell carcinoma of the skin","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Oculocutaneous_albinism"}